The earnings call reflects a company experiencing solid growth in certain areas such as general surgery and adjusted earnings, supported by operational improvements and a strong focus on supply chain stabilization. However, challenges persist in the orthopedic segment due to supply chain issues, and there are financial pressures from tariffs and FX. Despite these challenges, the company remains confident in its growth outlook and operational strategies.

Company Guidance -

Q3 2025

In the second quarter of fiscal 2025, CONMED reported total sales of $342.3 million, which slightly exceeded the high end of their guidance range, reflecting a year-over-year growth of 3.1% as reported and 2.9% in constant currency. The company's adjusted net income was $35.6 million, marking a 16.4% increase year-over-year, while adjusted diluted net earnings per share rose 17.3% to $1.15. CONMED's financial guidance for the full year anticipates revenue between $1.356 billion and $1.378 billion, with currency impacts expected to be neutral. For the third quarter, projected revenue is between $330 million and $337 million, with a slight FX tailwind. The company expects adjusted EPS for 2025 to range from $4.40 to $4.55, considering a $0.10 currency headwind and $0.09 tariff impact, marking a $0.09 increase from previous guidance. CONMED aims to achieve a leverage ratio below 3.0 by the end of 2025, enhancing financial flexibility for future investments.

Sales and Revenue Growth

Total sales for Q2 were $342.3 million, slightly above the high end of guidance. Year-over-year growth was 3.1% as reported and 2.9% in constant currency.

Adjusted Earnings Growth

Adjusted net income increased 16.4% year-over-year to $35.6 million, and adjusted diluted net earnings per share increased 17.3% year-over-year to $1.15.

General Surgery Segment Performance

Worldwide general surgery sales grew 4.4%, driven by platforms like AirSeal and legislative adoption in Buffalo Filter.

Orthopedic Segment Resilience

Despite ongoing supply chain challenges, orthopedic products grew, with BioBrace experiencing double-digit demand.

Supply Chain and Operational Improvements

Efforts to stabilize and scale operations are underway, with expectations to see significant improvements by year-end.

Debt and Leverage Management

Long-term debt decreased slightly, and the leverage ratio improved to 3.1x, better than expected. The company aims to reduce it below 3.0 by the end of 2025.

Conmed (CNMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CNMD Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 22, 2025	2025 (Q3)	1.05 / -	1.05	―	―	―
Jul 30, 2025	2025 (Q2)	1.12 / 1.15	0.98	17.35% (+0.17)
Apr 30, 2025	2025 (Q1)	0.81 / 0.95	0.79	20.25% (+0.16)
Feb 05, 2025	2024 (Q4)	1.20 / 1.34	1.06	26.42% (+0.28)
Oct 30, 2024	2024 (Q3)	1.02 / 1.05	0.9	16.67% (+0.15)
Jul 31, 2024	2024 (Q2)	0.91 / 0.98	0.83	18.07% (+0.15)
Apr 24, 2024	2024 (Q1)	0.74 / 0.79	0.66	19.70% (+0.13)
Jan 31, 2024	2023 (Q4)	1.11 / 1.06	0.42	152.38% (+0.64)
Oct 25, 2023	2023 (Q3)	0.84 / 0.90	0.77	16.88% (+0.13)
Jul 26, 2023	2023 (Q2)	0.79 / 0.83	0.76	9.21% (+0.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CNMD Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 30, 2025	$50.14	$51.15	+2.01%
Apr 30, 2025	$48.93	$56.98	+16.45%
Feb 05, 2025	$73.48	$66.88	-8.98%
Oct 30, 2024	$64.62	$67.56	+4.55%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Conmed (CNMD) report earnings?

Conmed (CNMD) is schdueled to report earning on Oct 22, 2025, After Close (Confirmed).

What is Conmed (CNMD) earnings time?

Conmed (CNMD) earnings time is at Oct 22, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is CNMD EPS forecast?

CNMD EPS forecast for the fiscal quarter 2025 (Q3) is 1.05.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing